Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Purpose. It has been reported that Th2 cytokines downregulate antitumor immunity, while activation of type T cells promotes antitumor immunity. The aim of this paper was to evaluate host immunity in liver cirrhosis (LC) patients with advanced hepatocellular carcinoma (aHCC) receiving sorafenib thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Hidenari, Mukozu, Takanori, Matsui, Daigo, Kanekawa, Takenori, Kanayama, Masahiro, Wakui, Noritaka, Momiyama, Kouichi, Shinohara, Mie, Iida, Kazunari, Ishii, Koji, Igarashi, Yoshinori, Sumino, Yasukiyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359796/
https://www.ncbi.nlm.nih.gov/pubmed/22666283
http://dx.doi.org/10.1155/2012/607851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359796/
https://www.ncbi.nlm.nih.gov/pubmed/22666283
http://dx.doi.org/10.1155/2012/607851

Ejemplares similares